Cathie Wood's Ark Innovation Fund surges 10%, on pace for best day ever

0

Widely followed investor Cathie Wood recouped some of her recent sharp losses as tech stocks rebounded Tuesday after a brutal correction triggered by surging bond yields.

Wood’s flagship active exchange-traded fund Ark Innovation ETF (ARKK) climbed more than 10% on Tuesday, on pace for its best day ever. Tesla, the fund’s biggest holding, is up 18%, Among other holdings, Zoom Video is up 8%, while Palantir gained 6.7%.

Another big holding Invitae is up 13% Tuesday. She told CNBC on Monday that the company, which operates in the molecular diagnostics space, is one of the firm’s most under-appreciated holdings.

The rebound in ‘ARKK’ came amid a 2.5% jump in the Nasdaq Composite as bond yields stabilized. The Nasdaq Composite dropped 4% on Monday, falling into correction territory, or more than 10% from its recent high.

Wood, who focuses on innovative technology, has seen stocks fitting her strategy get hammered lately amid a big market rotation out of high-flying tech and into cyclical value stocks in the face of higher rates. The fund lost 5.8% on Monday alone, pushing its 2021 losses to 11% as of Monday’s close.

Ark Innovation, however, did see $46 million in inflows on Monday as the ETF was dropping, a vote of confidence in the hot-handed investor.

High-growth names are hit particularly hard as rising rates make their future profits less valuable today, making the stocks’ lofty valuations less justifiable. Many of her big stakes experienced steep losses over the past month before Tuesday’s session: Tesla shed 33%, Zoom Video lost 27%, Palantir was down 41%.

The Ark Investment Management founder and CEO said Monday she is not concerned about the recent drop in her funds and she believes over time her disruptive strategy will pay off.

“Right now the market is broadening out and we think in an underlying sense the bull market is strengthening and that will play to our benefit over the longer term,” said Wood said on CNBC’s “Closing Bell” on Monday.

“We are getting great opportunities” in the sell-off to buy the pure play names in the funds, added Wood.

Ark Innovation purchased 748,201 shares if DraftKings on Monday, according to the firm’s disclosures. Wood also scooped up shares of Fate Therapeutics, Berkeley Lights and Beam Therapeutics.

Source

- Advertisement -

Leave A Reply

Your email address will not be published.